McKESSON CORPORATION Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
McKESSON CORPORATION (MCK) reported Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents of -$10.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-05
- McKESSON CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2026-06-30 was -$10.00M, a 130.30% decline year-over-year.
- McKESSON CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2025-06-30 was $33.00M.
- McKESSON CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2024-06-30 was -$5.00M, a 350.00% decline year-over-year.
- McKESSON CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2023-06-30 was $2.00M, a 88.89% decline year-over-year.
- McKESSON CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2026 was $20.00M.
- McKESSON CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2025 was -$16.00M, a 366.67% decline from fiscal 2024.
- McKESSON CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2024 was $6.00M, a 76.00% decline from fiscal 2023.
- McKESSON CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2023 was $25.00M, a 54.55% decline from fiscal 2022.
| Period end | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$10.00M 10-Q · filed 2026-08-05 | |||
| 2026-03-31 | $20.00M 10-K · filed 2026-05-08 | |||
| 2025-12-31 | $31.00M 10-Q · filed 2026-02-04 | |||
| 2025-09-30 | $24.00M 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | $33.00M 10-Q · filed 2026-08-05 | |||
| 2025-03-31 | -$16.00M 10-K · filed 2026-05-08 | |||
| 2024-12-31 | -$21.00M 10-Q · filed 2026-02-04 | |||
| 2024-09-30 | $1.00M 10-Q · filed 2025-11-06 | |||
| 2024-06-30 | -$5.00M 10-Q · filed 2025-08-06 | |||
| 2024-03-31 | $6.00M 10-K · filed 2026-05-08 | |||
| 2023-12-31 | $6.00M 10-Q · filed 2025-02-06 | |||
| 2023-09-30 | -$1.00M 10-Q · filed 2024-11-07 | |||
| 2023-06-30 | $2.00M 10-Q · filed 2024-08-07 | |||
| 2023-03-31 | $25.00M 10-K · filed 2025-05-09 | |||
| 2022-12-31 | $15.00M 10-Q · filed 2024-02-08 | |||
| 2022-09-30 | $24.00M 10-Q · filed 2023-11-02 | |||
| 2022-06-30 | $18.00M 10-Q · filed 2023-08-02 | |||
| 2022-03-31 | $55.00M 10-K · filed 2024-05-08 | |||
| 2021-12-31 | $35.00M 10-Q · filed 2023-02-02 | |||
| 2021-09-30 | $18.00M 10-Q · filed 2022-11-02 | |||
| 2021-06-30 | $11.00M 10-Q · filed 2022-08-04 | |||
| 2021-03-31 | -$61.00M 10-K · filed 2023-05-09 | |||
| 2020-12-31 | -$77.00M 10-Q · filed 2022-02-03 | |||
| 2020-09-30 | -$63.00M 10-Q · filed 2021-11-02 | |||
| 2020-06-30 | -$28.00M 10-Q · filed 2021-08-05 | |||
| 2020-03-31 | -$19.00M 10-K · filed 2022-05-09 | |||
| 2019-12-31 | $27.00M 10-Q · filed 2021-02-02 | |||
| 2019-09-30 | $22.00M 10-Q · filed 2020-11-03 | |||
| 2019-06-30 | $18.00M 10-Q · filed 2020-08-03 | |||
| 2019-03-31 | -$119.00M 10-K · filed 2021-05-12 | |||
| 2018-12-31 | -$130.00M 10-Q · filed 2020-02-04 | |||
| 2018-09-30 | -$87.00M 10-Q · filed 2019-10-30 | |||
| 2018-06-30 | -$78.00M 10-Q · filed 2019-08-01 | |||
| 2018-03-31 | $150.00M 10-K · filed 2020-05-22 | |||
| 2017-12-31 | $143.00M 10-Q · filed 2019-01-31 | |||
| 2017-09-30 | $109.00M 10-Q · filed 2018-10-25 | |||
| 2017-06-30 | $75.00M 10-Q · filed 2018-07-26 | |||
| 2017-03-31 | -$144.00M 10-K · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B |